Ep201: Jeremy Levin on Biotech in the Balance episode artwork

EPISODE · May 19, 2026 · 1H 8M

Ep201: Jeremy Levin on Biotech in the Balance

from The Long Run with Luke Timmerman · host Timmerman Report

Jeremy Levin, executive chair of Ovid Therapeutics, discusses his new book "Biotech in the Balance: Saving a Strategic Industry in an Age of Distrust."

Jeremy Levin, executive chair of Ovid Therapeutics, discusses his new book "Biotech in the Balance: Saving a Strategic Industry in an Age of Distrust."

NOW PLAYING

Ep201: Jeremy Levin on Biotech in the Balance

0:00 1:08:40

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Long Run with Luke Timmerman?

This episode is 1 hour and 8 minutes long.

When was this The Long Run with Luke Timmerman episode published?

This episode was published on May 19, 2026.

What is this episode about?

Jeremy Levin, executive chair of Ovid Therapeutics, discusses his new book "Biotech in the Balance: Saving a Strategic Industry in an Age of Distrust."

Can I download this The Long Run with Luke Timmerman episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!